Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | ADRB1 | P08588 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 3/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | MGLL | Q99685 | 1/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.35 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.34 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1156328 | 0.90 | ALDH1A1 (0.48) | SMN1; SMN2ALDH1A1HPGDADRB1MEN1 | |
| Hydrochloric Acid SCHEMBL1155766 | 0.88 | ALDH1A1 (0.47) | SMN1; SMN2ALDH1A1HPGDADRB1MEN1 | |
| SCHEMBL820124 | 0.88 | CYP1A2 (0.38) | ALDH1A1MEN1KMT2AMAPTTSHR | |
| Iodide SCHEMBL28719254 | 0.86 | KDM4E (0.38) | ALDH1A1MEN1KMT2AMAPTTSHR | |
| SCHEMBL29672565 | 0.86 | CYP1A2 (0.36) | ALDH1A1MEN1KMT2AMAPTTSHR | |
| Hydrochloric Acid SCHEMBL820541 | 0.86 | CYP1A2 (0.36) | ALDH1A1MEN1KMT2AMAPTTSHR | |
| SCHEMBL20365239 | 0.83 | ALDH1A1 (0.40) | SMN1; SMN2ALDH1A1HPGDADRB1MGLL | |
| SCHEMBL22427651 | 0.81 | MAPT (0.36) | SMN1; SMN2ALDH1A1MEN1KMT2AMAPT | |
| SCHEMBL12514330 | 0.81 | ALDH1A1 (0.41) | SMN1; SMN2ALDH1A1HPGDADRB1MEN1 | |
| SCHEMBL16728719 | 0.78 | SMN1; SMN2 (0.42) | SMN1; SMN2ALDH1A1HPGDADRB1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10276805-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2019-04-30 | — | — | US | disclosed |
| US-20180090691-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2018-03-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180090691-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | EML4, TYR, CPNE4 | SMN1; SMN2 2417/4885ALDH1A1 2007/4885HPGD 3249/4885 |
| US-10276805-B2 | Organic electroluminescent materials and devices | EML4, TYR, CPNE4 | SMN1; SMN2 2417/4885ALDH1A1 2007/4885HPGD 3249/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.